Abstract
BackgroundA number of Janus kinase (JAK) inhibitors are being actively investigated for treatment of rheumatoid arthritis (RA), including tofacitinib, baricitinib, filgotinib (GLPG0634), and decernotinib (VX-509). However, it is unclear how...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have